DNA synthesis inhibition in response to benzo[a]pyrene dihydrodiol epoxide is associated with attenuation of p34cdc2: Role of p53

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 755, Issue 1, 2013, Pages 61-67

  Mukherjee, Jagat J ^a   Kumar, Subodh ^a  

^a BUFFALO STATE COLLEGE   (United States)

Author keywords

( ) Anti benzo a pyrene 7,8 diol 9,10 epoxide; Cell growth inhibition; DNA synthesis; P21; P53; P34cdc2

Indexed keywords

BENZO[A]PYRENE DIHYDRODIOL EPOXIDE; CYCLIN DEPENDENT KINASE 1; POLYCYCLIC AROMATIC HYDROCARBON; PROTEIN P21; PROTEIN P53; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; DOWN REGULATION; FIBROBLAST; GENETIC TRANSFECTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

(±)-ANTI-BENZO[A]PYRENE-7,8-DIOL-9,10-EPOXIDE; CELL GROWTH INHIBITION; DNA SYNTHESIS; P(34)CDC2; P21; P53;

7,8-DIHYDRO-7,8-DIHYDROXYBENZO(A)PYRENE 9,10-OXIDE; APOPTOSIS; BLOTTING, WESTERN; CARCINOGENS; CDC2 PROTEIN KINASE; CELL PROLIFERATION; CELLS, CULTURED; COLONIC NEOPLASMS; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; EPIDERMIS; FIBROBLASTS; HUMANS; LUNG; RNA, SMALL INTERFERING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84880046788     PISSN: 13835718     EISSN: 18793592     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2013.05.009     Document Type: Article

References (54)

1. Orris L. Carcinogenicity for mouse skin and aromatic hydrocarbon content of cigarette-smoke condensate. J. Natl. Cancer Inst. 1958, 21:557-561.
2. Hoffmann D., Hecht S.S. Advances in tobacco carcinogenesis. Handbook of Experimental Pharmacology 1990, vol. 94/1:63-102. Springer-Verlag, Heidelberg.
3. Hecht S.S. Approaches to chemoprevention of lung cancer based on carcinogens in tobacco smoke. Environ. Health Perspect. 1997, 105:955-963.
4. Pelkonen O., Nebert D.W. Metabolism of polycyclic aromatic hydrocarbons: etiologic role in carcinogenesis. Pharmacol. Rev. 1982, 34:189-222.
5. Stampfer M.R., Bartley J.C. Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo(a)pyrene. Proc. Natl. Acad. Sci. U.S.A. 1985, 82:2394-2398.
6. Harvey R.G. Polycyclic Aromatic Hydrocarbons: Chemistry and Carcinogenicity 1991, 396. Cambridge University Press, Cambridge.
7. Van Durren B.L. Identification of some polynuclear aromatic hydrocarbons in cigarette-smoke condensate. J. Natl. Cancer Inst. 1958, 21:1-16.
8. Gellhorn A. The carcinogenic activity of cigarette tobacco tar. Cancer Res. 1958, 18:510-517.
9. Heidelberger C. Chemical carcinogenesis. Annu. Rev. Biochem. 1975, 44:79-121.
10. Lasne C., Gentil A., Chouroulinkov I. Two-stage carcinogenesis with rat embryo cells in tissue culture. Br. J. Cancer 1977, 35:722-729.
11. Miller M.L., et al. The tumor promoter TPA enhances benzo[a]pyrene and benzo[a]pyrene diol epoxide mutagenesis in Big Blue mouse skin. Environ. Mol. Mutagen 2000, 35:319-327.
12. Lowe S.W., Cepero E., Evan G. Intrinsic tumour suppression. Nature 2004, 432:307-315.
13. Fritsche M., Haessler C., Brandner G. Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene 1993, 8:307-318.
14. Maltzman W., Czyzyk L. UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol. Cell. Biol. 1984, 4:1689-1694.
15. Kuerbitz S.J., Plunkett B.S., Walsh W.V., Kastan M.B. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:7491-7495.
16. Bjelogrlic N.M., Makinen M., Stenback F., Vahakangas K. Benzo[a]pyrene-7,8-diol-9,10-epoxide-DNA adducts and increased p53 protein in mouse skin. Carcinogenesis 1994, 15:771-774.
17. Stuart D., Khan Q.A., Brown R., Dipple A. Hydrocarbon carcinogens induce p53 activity in normal mouse tissue. Cancer Lett. 2001, 173:111-114.
18. Binkova B., Giguere Y., Rossner P., Dostal M., Sram R.J. The effect of dibenzo[a,l]pyrene and benzo[a]pyrene on human diploid lung fibroblasts: the induction of DNA adducts, expression of p53 and p21(WAF1) proteins and cell cycle distribution. Mutat. Res. 2000, 471:57-70.
19. Venkatachalam S., Denissenko M., Wani A.A. Modulation of (+/-)-anti-BPDE mediated p53 accumulation by inhibitors of protein kinase C and poly(ADP-ribose) polymerase. Oncogene 1997, 14:801-809.
20. Shackelford R.E., Kaufmann W.K., Paules R.S. Cell cycle control, checkpoint mechanisms, and genotoxic stress. Environ. Health Perspect. 1999, 107:5-24.
21. Kastan M.B. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 1991, 51:6304-6311.
22. Agarwal M.L., et al. p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:8493-8497.
23. Stewart N., Hicks G.G., Paraskevas F., Mowat M. Evidence for a second cell cycle block at G2/M by p53. Oncogene 1995, 10:109-115.
24. 2 arrest after DNA damage. Science 1998, 282:1497-1501.
25. Chernova O.B., et al. The role of p53 in regulating genomic stability when DNA and RNA synthesis are inhibited. Trends Biochem. Sci. 1995, 20:431-434.
26. Agarwal M.L., et al. A p53-dependent S-phase checkpoint helps to protect cells from DNA damage in response to starvation for pyrimidine nucleotides. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:14775-14780.
27. Taylor W.R., et al. p53 inhibits entry into mitosis when DNA synthesis is blocked. Oncogene 1999, 18:283-295.
28. El-Deiry W.S., et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993, 75:817-825.
29. Xiong Y., et al. p21 is a universal inhibitor of cyclin kinases. Nature 1993, 366:701-704.
30. Harper J.W., et al. The p21 Cdk-interacting protein Cipl is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993, 75:805-816.
31. Furukara Y., et al. CDC2 gene expression at the G1 to S transition in human T lymphocytes. Science 1990, 250:805-808.
32. Draetta G., Beach D. Activation of cdc2 protein kinase during mitosis in human cells: cell cycle-dependent phosphorylation and subunit rearrangement. Cell 1988, 54:17-26.
33. Giordano A., et al. A 60 kd cdc2-associated polypeptide complexes with the E1A proteins in adenovirus-infected cells. Cell 1989, 58:981-990.
34. Azzam E.I., et al. CDC2 is down-regulated by ionizing radiation in a p53-dependent manner. Cell Growth Differ. 1997, 8:1161-1169.
35. Le Gac G., et al. DNA damage-induced down-regulation of human Cdc25C and Cdc2 is mediated by cooperation between p53 and maintenance DNA (cytosine-5) methyltransferase 1. J. Biol. Chem. 2006, 281:24161-24170.
36. Nurse P. Ordering S phase and M phase in the cell cycle. Cell 1994, 79:547-550.
37. Paulovich A.G., Toczyski D.P., Hartwell L.H. When checkpoints fail. Cell 1997, 88:315-321.
38. Kaufmann W.K., Paulest R.S. DNA damage and cell cycle checkpoints. FASEB J. 1996, 10:238-247.
39. Wang L., et al. Analyses of p53 target genes in the human genome by bioinformatic and microarray approaches. J. Biol. Chem. 2001, 276:43604-43610.
40. Price B.D., Calderwood S.K. Increased sequence-specific p53-DNA binding activity after DNA damage is attenuated by phorbol esters. Oncogene 1993, 11:3055-3062.
41. Mukherjee J.J., Kumar S., Gocinski R., Williams J. Phenolic fraction of tobacco smoke inhibits BPDE-induced apoptosis response and potentiates cell transformation: role of attenuation of p53 response. Chem. Res. Toxicol. 2011, 24:698-705.
42. Mukherjee J.J., Gupta S.K., Kumar S., Sikka H.C. Effects of cadmium(II) on (+/-)-anti-benzo[a]pyrene-7,8-diol-9,10-epoxide-induced DNA damage response in human fibroblasts and DNA repair: a possible mechanism of cadmium's co-genotoxicity. Chem. Res. Toxicol. 2004, 17:287-293.
43. Chernov M.V., et al. Stabilization and activation of p53 are regulated independently by different phosphorylation events. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:2284-2289.
44. Taylor W.R., et al. p130/E2F4 binds to and represses the cdc2 promoter in response to p53. J. Biol. Chem. 2001, 276. 1998-2006.
45. 34cdc2 in transformed cells. EMBO J. 1990, 9:2885-2889.
46. 34cdc2 homologues. Biochim. Biophys. Acta 1989, 989:85-95.
47. Nurse P. Universal control mechanism regulating onset of M-phase. Nature 1990, 344:503-508.
48. Pines J., Hunter T. Cdc2 p34: the S and M kinase?. New Biol. 1990, 2:389-401.
49. Lin C.H., et al. Molecular topology of polycyclic aromatic carcinogens determines DNA adduct conformation: a link to tumorigenic activity. J. Mol. Biol. 2001, 306:1059-1080.
50. Wang J., et al. Inhalation cancer risk associated with exposure to complex polycyclic aromatic hydrocarbon mixtures in an electronic waste and urban area in south China. Environ. Sci. Technol. 2012, 46:9745-9752.
51. Armstrong B., et al. lung cancer risk after exposure to polycyclic aromatic hydrocarbons: a review and meta-analysis. Environ. Health Perspect. 2004, 112:970-978.
52. Aliouat-Denis C.M., et al. p53-independent regulation of p21Waf1/Cip1 expression and senescence by Chk2. Mol. Cancer Res. 2005, 11:627-674.
53. Jeong J.-H., et al. p53-Independent Induction of G1 Arrest and p21WAF1/CIP1 expression by ascofuranone, an isoprenoid antibiotic, through downregulation of c-myc. Mol. Cancer Ther. 2010, 9:2102-2113.
54. Ashcroft M., et al. Regulation of p53 function and stability by phosphorylation. Mol. Cell. Biol. 1999, 19:1751-1758.